ReposiTrak Inc (TRAK) Stock Analysis
Verdict: WATCH (do not buy)
High software margins and net cash backstop valuation, but persistent insider selling and three recent earnings misses cap upside.
Investment score: 49/100
Analysis as of
Is ReposiTrak Inc stock worth reviewing? The TradeMates thesis
The model views ReposiTrak as a high-margin, cash-rich micro-cap SaaS provider whose growth deceleration, insider selling, and earnings miss history justify a Hold rating.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 85/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 15/100 (weight 10%)
- Analyst Consensus: 65/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
ReposiTrak Inc opportunities and risks
What speaks for TRAK
- FDA Food Traceability Rule (FSMA 204) mandate tailwind
What speaks against TRAK
- Heavy and persistent executive insider selling
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TRAK | 21.4x | 6.5x | 13.2x | 85.0% | 31.0% | 4.9% |
| DOMO | n/a | 0.5x | n/a | 75.4% | -13.4% | -5.2% |
| ZPTA | 17.1x | 0.0x | n/a | 0.0% | 0.0% | 0.1% |
| TONX | n/a | 5.9x | n/a | 83.1% | -533.5% | -16.8% |
| EGAN | 16.9x | 1.6x | 6.1x | 73.4% | 9.7% | 13.8% |
| Peer median | 7.6x | 1.1x | n/a | 74.4% | -6.7% | -2.5% |
Frequently asked questions about ReposiTrak Inc (TRAK)
Is TRAK stock a good investment?
The TradeMates model rates ReposiTrak Inc as WATCH (do not buy) with an investment score of 49/100. The model views ReposiTrak as a high-margin, cash-rich micro-cap SaaS provider whose growth deceleration, insider selling, and earnings miss history justify a Hold rating. This is algorithmic model output, not personal investment advice.
Is TRAK stock a buy?
The TradeMates model verdict for TRAK is WATCH (do not buy) with an investment score of 49/100. Treat this as a model signal to review, not a personal buy recommendation.